Search Results - "Sakaeva, I. V."

Phagocytic Activity of N-Vinylpyrrolidone and 2-Methyl-5-vinylpyridine Copolymers by Kedik, S. A., Panov, A. V., Sakaeva, I. V., Kochkina (Cherta), Yu. V., Yartsev, E. I.

“…A copolymer of N -vinylpyrrolidone and 2-methyl-5-vinylpyridine was shown to increase the phagocytic activity of macrophages. A tendency of the fraction of…”
Get full text

Synthesis and radioprotector activity of N-vinylpyrrolidone and 2-methyl-5-vinyltetrazole copolymers by Kedik, S. A., Sakaeva, I. V., Kochkina (Cherta), Yu. V., Eremin, D. V., Panov, A. V., Suslov, V. V.

“…Copolymers of N -vinylpyrrolidone and 2-methyl-5-vinyltetrazole with various ratios of monomer units were synthesized by radical polymerization using the…”
Get full text

Quantitative Determination in Aqueous Solutions of Physiologically Active Copolymers of N-Vinylpyrrolidone and 2-Methyl-5-Vinylpyridine by Kedik, S. A., Panov, A. V., Sakaeva, I. V., Kochkina (Cherta), Yu. V., Eremin, D. V., Suslov, V. V., Zaitsev, M. A.

“…Techniques for quantitative determination of N -vinylpyrrolidone and 2-methyl-5-vinylpyridine copolymers in aqueous solutions were developed. The…”
Get full text

Synthesis and molecular-weight characteristics of n-vinylpyrrolidone and 2-methyl-5-vinylpyridine copolymers by Kedik, S. A., Panov, A. V., Sakaeva, I. V., Kochkina(Cherta), Yu. V., Eremin, D. V., Suslov, V. V.

“…N -Vinylpyrrolidone and 2-methyl-5-vinylpyridine copolymers with various ratios of monomer units and molecular weights were synthesized by radical…”
Get full text

Formation of ultrathin protective films for ophthalmological use from aqueous solutions of polymers and taurine by Kedik, S. A., Levachev, S. M., Panov, A. V., Sakaeva, I. V., Kharlov, A. E., Grigor’eva, O. A., Zhavoronok, E. S., Cherta, Yu. V., Zaitsev, M. A., An, Ha Kam

“…Aqueous dextran solutions, polyhexamethyleneguanidine hydrochloride and Sovidone and their mixtures with taurine were used to form stable ultrathin protective…”
Get full text

Approaches to eye drops efficiency evaluation based on physicochemical characteristics by Kedik, S. A., Yartsev, E. I., Levachev, S. M., Panov, A. V., Sakaeva, I. V., Grigor’eva, O. A., Zhavoronok, E. S., Cherta, Yu. V., Zaitsev, M. A., An, Ha Kam

“…A new approach to the formulation of eye drops containing the active substance taurine and adjuvant polymers such as dextran, poly(hexamethyleneguanidine)…”
Get full text

RETRACTED: International experience in drug names assessment: European Medicines Agency by A. N. Mironov, I. V. Sakaeva, V. V. Dudchenko, L. V. Korneeva, A. N. Yavorsky

“…RETRACTED ARTICLEThe present article considers the experience of a unitary expert and control authority regulating the circulation of medicines in the European…”
Get full text

Preparations of next generation monoclonal antibodies (issues and prospects) by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, N. V. Medunitsyn, V. P. Bondarev, A. N. Mironov, V. A. Merkulov, I. V. Sakaeva

“…The article provides the information on issues related to the clinical use of preparations of monoclonal antibodies (MAb), and the prospects for developing…”
Get full text